Characterization of human flavin-containing monooxygenase (FMO) 3 and FMO5 expressed as maltose-binding protein fusions

Drug Metabolism and Disposition

Volumn 38, Issue 12, 2010, Pages 2239-2245

  Reddy, Robert R ^a   Ralph, Erik C ^a   Motika, Meike S ^a   Zhang, Jun ^a   Cashman, John R ^a  

^a HUMAN BIOMOLECULAR RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYLANILINE MONOOXYGENASE; FLAVIN CONTAINING MONOOXYGENASE 3; FLAVIN CONTAINING MONOOXYGENASE 5; MALTOSE BINDING PROTEIN; RECOMBINANT PROTEIN; TRITON X 100; UNCLASSIFIED DRUG;

ARTICLE; HUMAN; HUMAN CELL; INSECT CELL; KINETICS; NUCLEOTIDE SEQUENCE; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION;

HUMANS; KINETICS; MALTOSE-BINDING PROTEINS; OXYGENASES; RECOMBINANT FUSION PROTEINS;

HEXAPODA;

EID: 78649565707     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.110.033639     Document Type: Article

References (30)

1. Brunelle A, Bi YA, Lin J, Russell B, Luy L, Berkman C, and Cashman J (1997) Characterization of two human flavin-containing monooxygenase (form 3) enzymes expressed in Escherichia coli as maltose binding protein fusions. Drug Metab Dispos 25:1001-1007. (Pubitemid 27357699)
2. Cashman JR (2008) Role of flavin-containing monooxgenase in drug development. Expert Opin Drug Metab Toxicol 4:1507-1521.
3. Cashman JR, Xiong YN, Xu L, and Janowsky A (1999) N-Oxygenation of amphetamine and methamphetamine by the human flavin-containing monooxygenase (form 3): role in bioactivation and detoxication. J Pharmacol Exp Ther 288:1251-1260.
4. Dixit A and Roche TE (1984) Spectrophotometric assay of the flavin-containing monooxygenase and changes in its activity in female mouse liver with nutritional and diurnal conditions. Arch Biochem Biophys 233:50-63.
5. Elfarra AA and Krause RJ (2005) Potential roles of flavin-containing monooxygenases in sulfoxidation reactions of L-methionine, N-acetyl-L-methionine and peptides containing Lmethionine. Biochim Biophys Acta 1703:183-189.
6. Fox JD and Waugh DS (2003) Maltose-binding protein as a solubility enhancer. Methods Mol Biol 205:99-117.
7. Haining RL, Hunter AP, Sadeque AJ, Philpot RM, and Rettie AE (1997) Baculovirus-mediated expression and purification of human FMO3: catalytic, immunochemical, and structural characterization. Drug Metab Dispos 25:790-797.
8. Kapust RB and Waugh DS (1999) Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused. Protein Sci 8:1668-1674.
9. Krueger SK, Siddens LK, Henderson MC, VanDyke JE, Karplus PA, Pereira CB, and Williams DE (2006) C-Terminal truncation of rabbit flavin-containing monooxygenase isoform 2 enhances solubility. Arch Biochem Biophys 450:149-156.
10. Krueger SK and Williams DE (2005) Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism. Pharmacol Ther 106:357-387.
11. Lang DH, Yeung CK, Peter RM, Ibarra C, Gasser R, Itagaki K, Philpot RM, and Rettie AE (1998) Isoform specificity of trimethylamine N-oxygenation by human flavin-containing monooxygenase (FMO) and P450 enzymes: selective catalysis by FMO3. Biochem Pharmacol 56:1005-1012.
12. Lattard V, Zhang J, Tran Q, Furnes B, Schlenk D, and Cashman JR (2003) Two new polymorphisms of the FMO3 gene in Caucasian and African-American populations: comparative genetic and functional studies. Drug Metab Dispos 31:854-860.
13. Lomri N, Thomas J, and Cashman JR (1993) Expression in Escherichia coli of the cloned flavin-containing monooxygenase from pig liver. J Biol Chem 268:5048-5054.
14. Motika MS, Zhang J, and Cashman JR (2007) Flavin-containing monooxygenase 3 and human disease. Expert Opin Drug Metab Toxicol 3:831-845.
15. Motika MS, Zhang J, Zheng X, Riedler K, and Cashman JR (2009) Novel variants of the human flavin-containing monooxygenase 3 (FMO3) gene associated with trimethylaminuria. Mol Genet Metab 97:127-135.
16. Nagata T, Williams DE, and Ziegler DM (1990) Substrate specificities of rabbit lung and porcine liver flavin-containing monooxygenases: differences due to substrate size. Chem Res Toxicol 3:372-376.
17. Overby LH, Carver GC, and Philpot RM (1997) Quantitation and kinetic properties of hepatic microsomal and recombinant flavin-containing monooxygenases 3 and 5 from humans. Chem Biol Interact 106:29-45.
18. Palfey BA and McDonald CA (2010) Control of catalysis in flavin-dependent monooxygenases. Arch Biochem Biophys 493:26-36.
19. Pattenden LK and Thomas WG (2008) Amylose affinity chromatography of maltose-binding protein: purification by both native and novel matrix-assisted dialysis refolding methods. Methods Mol Biol 421:169-189.
20. Poulsen LL and Ziegler DM (1995) Multisubstrate flavin-containing monooxygenases: applications of mechanism to specificity. Chem Biol Interact 96:57-73.
21. Rettie AE, Bogucki BD, Lim I, and Meier GP (1990) Stereoselective sulfoxidation of a series of alkyl p-tolyl sulfides by microsomal and purified flavin-containing monooxygenases. Mol Pharmacol 37:643-651.
22. Venkatesh K, Levi PE, and Hodgson E (1991) The effect of detergents on the purified flavin-containing monooxygenase of mouse liver, kidney and lungs. Gen Pharmacol 22:549-552.
23. Wagner MA, Khanna P, and Jorns MS (1999) Structure of the flavocoenzyme of two homologous amine oxidases: monomeric sarcosine oxidase and N-methyltryptophan oxidase. Biochemistry 38:5588-5595.
24. Wang L, Christopher LJ, Cui D, Li W, Iyer R, Humphreys WG, and Zhang D (2008) Identification of the human enzymes involved in the oxidative metabolism of dasatinib: an effective approach for determining metabolite formation kinetics. Drug Metab Dispos 36:1828-1839.
25. Washio T, Arisawa H, Kohsaka K, and Yasuda H (2001) Identification of human drug-metabolizing enzymes involved in the metabolism of SNI-2011. Biol Pharm Bull 24:1263-1266.
26. Yeung CK, Adman ET, and Rettie AE (2007) Functional characterization of genetic variants of human FMO3 associated with trimethylaminuria. Arch Biochem Biophys 464:251-259.
27. Zhang J and Cashman JR (2006) Quantitative analysis of FMO gene mRNA levels in human tissues. Drug Metab Dispos 34:19-26.
28. Zhang J, Cerny MA, Lawson M, Mosadeghi R, and Cashman JR (2007) Functional activity of the mouse flavin-containing monooxygenase forms 1, 3, and 5. J Biochem Mol Toxicol 21:206-215.
29. Zhang J, Tran Q, Lattard V, and Cashman JR (2003) Deleterious mutations in the flavin-containing monooxygenase 3 (FMO3) gene causing trimethylaminuria. Pharmacogenetics 13:495-500.
30. Ziegler DM and Mitchell CH (1972) Microsomal oxidase. IV. Properties of a mixed-function amine oxidase isolated from pig liver microsomes. Arch Biochem Biophys 150:116-125.